FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387404220> ?p ?o ?g. }

• W4387404220 endingPage "2516" @default.
• W4387404220 startingPage "2499" @default.
• W4387404220 abstract "Filgotinib is an orally administered, preferential Janus kinase (JAK) inhibitor indicated for the treatment of moderate-to-severe rheumatoid arthritis (RA). The short-term safety, efficacy, and patient-reported outcomes (PROs) with filgotinib from Phase 2b/3 clinical trials (DARWIN 1 and 2; FINCH 1, 2, and 3) are described in patients who inadequately responded to methotrexate (MTX) and biologic disease-modifying antirheumatic drugs or who were naïve to MTX. This article reviews the safety and efficacy from the long-term extension (LTE) trials, DARWIN 3 (N=739) and FINCH 4 (N=2731), and PROs across the filgotinib development program in RA. Overall, in the DARWIN clinical trials (conducted from 2013-2023), patients received their LTE treatment for ≤8 years, while in the FINCH trials (ongoing from 2016-2025), patients received filgotinib treatment for ≤6 years in the LTE. The longer-term safety profile and consistent, sustained efficacy (American College of Rheumatology 20/50/70, Clinical Disease Activity Index, and Disease Activity Scale in 28 joints with C-reactive protein response rates) of filgotinib were largely similar to those observed in the shorter-term parent trials ≤52 weeks. PRO results from the parent trials showed improvements in patients' quality of life with filgotinib treatment, which compared to or exceeded improvements seen with placebo and active comparators (adalimumab, MTX). Filgotinib has a higher specificity for JAK1 compared with other therapeutic treatments, leading to reduced inhibition of JAK2/3-dependent pathways, potentially providing a distinct safety profile. Filgotinib is approved in Europe and Japan for treatment of people with moderate-to-severe RA, though it has not been approved by the US Food and Drug Administration, due to concerns around the benefit/risk profile of the filgotinib 200-mg dosage and the potential impact on semen parameters." @default.
• W4387404220 created "2023-10-07" @default.
• W4387404220 creator A5003819213 @default.
• W4387404220 creator A5068792317 @default.
• W4387404220 creator A5086478930 @default.
• W4387404220 date "2023-10-01" @default.
• W4387404220 modified "2023-10-14" @default.
• W4387404220 title "Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives" @default.
• W4387404220 cites W1967469251 @default.
• W4387404220 cites W2062203442 @default.
• W4387404220 cites W2066963386 @default.
• W4387404220 cites W2077156933 @default.
• W4387404220 cites W2077550414 @default.
• W4387404220 cites W2117219551 @default.
• W4387404220 cites W2120965955 @default.
• W4387404220 cites W2159106700 @default.
• W4387404220 cites W2335898267 @default.
• W4387404220 cites W2431304589 @default.
• W4387404220 cites W2555199232 @default.
• W4387404220 cites W2562753811 @default.
• W4387404220 cites W2566103724 @default.
• W4387404220 cites W2584430503 @default.
• W4387404220 cites W2602398283 @default.
• W4387404220 cites W2792363356 @default.
• W4387404220 cites W2807791746 @default.
• W4387404220 cites W2808333862 @default.
• W4387404220 cites W2912849003 @default.
• W4387404220 cites W2962938985 @default.
• W4387404220 cites W2981666147 @default.
• W4387404220 cites W3002498794 @default.
• W4387404220 cites W3038997989 @default.
• W4387404220 cites W3039530223 @default.
• W4387404220 cites W3048528702 @default.
• W4387404220 cites W3085095620 @default.
• W4387404220 cites W3092984391 @default.
• W4387404220 cites W3094882380 @default.
• W4387404220 cites W3097773625 @default.
• W4387404220 cites W3102563980 @default.
• W4387404220 cites W3107627691 @default.
• W4387404220 cites W3118646829 @default.
• W4387404220 cites W3124339251 @default.
• W4387404220 cites W3128990629 @default.
• W4387404220 cites W3136549884 @default.
• W4387404220 cites W3136857317 @default.
• W4387404220 cites W3165054640 @default.
• W4387404220 cites W3183969235 @default.
• W4387404220 cites W3186518096 @default.
• W4387404220 cites W3210178764 @default.
• W4387404220 cites W4205276722 @default.
• W4387404220 cites W4205582589 @default.
• W4387404220 cites W4207035552 @default.
• W4387404220 cites W4281488230 @default.
• W4387404220 cites W4283711720 @default.
• W4387404220 cites W4289545208 @default.
• W4387404220 cites W4289638284 @default.
• W4387404220 cites W4303859853 @default.
• W4387404220 cites W4308769923 @default.
• W4387404220 cites W4312191248 @default.
• W4387404220 doi "https://doi.org/10.2147/ppa.s417677" @default.
• W4387404220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37822545" @default.
• W4387404220 hasPublicationYear "2023" @default.
• W4387404220 type Work @default.
• W4387404220 citedByCount "0" @default.
• W4387404220 crossrefType "journal-article" @default.
• W4387404220 hasAuthorship W4387404220A5003819213 @default.
• W4387404220 hasAuthorship W4387404220A5068792317 @default.
• W4387404220 hasAuthorship W4387404220A5086478930 @default.
• W4387404220 hasBestOaLocation W43874042201 @default.
• W4387404220 hasConcept C126322002 @default.
• W4387404220 hasConcept C142724271 @default.
• W4387404220 hasConcept C204787440 @default.
• W4387404220 hasConcept C27081682 @default.
• W4387404220 hasConcept C2777575956 @default.
• W4387404220 hasConcept C2780132546 @default.
• W4387404220 hasConcept C2781059491 @default.
• W4387404220 hasConcept C535046627 @default.
• W4387404220 hasConcept C71924100 @default.
• W4387404220 hasConceptScore W4387404220C126322002 @default.
• W4387404220 hasConceptScore W4387404220C142724271 @default.
• W4387404220 hasConceptScore W4387404220C204787440 @default.
• W4387404220 hasConceptScore W4387404220C27081682 @default.
• W4387404220 hasConceptScore W4387404220C2777575956 @default.
• W4387404220 hasConceptScore W4387404220C2780132546 @default.
• W4387404220 hasConceptScore W4387404220C2781059491 @default.
• W4387404220 hasConceptScore W4387404220C535046627 @default.
• W4387404220 hasConceptScore W4387404220C71924100 @default.
• W4387404220 hasLocation W43874042201 @default.
• W4387404220 hasLocation W43874042202 @default.
• W4387404220 hasOpenAccess W4387404220 @default.
• W4387404220 hasPrimaryLocation W43874042201 @default.
• W4387404220 hasRelatedWork W2020756831 @default.
• W4387404220 hasRelatedWork W2106806370 @default.
• W4387404220 hasRelatedWork W2138243862 @default.
• W4387404220 hasRelatedWork W2314544353 @default.
• W4387404220 hasRelatedWork W2352867790 @default.
• W4387404220 hasRelatedWork W2366611537 @default.
• W4387404220 hasRelatedWork W2396165291 @default.
• W4387404220 hasRelatedWork W2411121127 @default.

• next